Trial intelligence / Profile preview

Simvastatin for high-fat diet-induced airway inflammation in asthma

ACTRN12609000977279Phase 3Completed

Sponsor
Prof Lisa Wood
Start
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in asthma comparing Simvastatin with Placebo (2 arms). Primary endpoint: Postprandial change in sputum neutrophils. Started Dec 2009; status: completed.

02

Drugs

simvastatin
03

Conditions

asthma

Beyond the preview

Go deeper on ACTRN12609000977279.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12609000977279.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call